Apex Biotechnology Corp Cash Flow Reinvestment Rate
Apex Biotechnology Corp cash flow reinvestment rate. Apex Biotechnology Corp (1733) has a Cash Flow Reinvestment Rate of 1.77x as of September 2025, reinvesting NT$9.17 Million (capex NT$2.97 Million plus investments NT$6.21 Million) from operating cash flow of NT$5.19 Million. Explore how well can Apex Biotechnology Corp service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Apex Biotechnology Corp (2002–2024)
Cash flow reinvestment rate of Apex Biotechnology Corp from 2002 to 2024. Historical reinvestment intensity for Apex Biotechnology Corp across 23 annual periods. Explore Apex Biotechnology Corp capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Apex Biotechnology Corp Cash Flow Reinvestment Rate by Year (2002–2024)
Apex Biotechnology Corp cash flow reinvestment rate by year from 2002 to 2024. Year-by-year capital reinvestment analysis for Apex Biotechnology Corp. For the full cash flow conversion analysis, see cash efficiency ratio of Apex Biotechnology Corp.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.11x | NT$35.63 Million | NT$328.67 Million | NT$29.63 Million | ▼ -47.4% |
| 2023 | 0.21x | NT$47.48 Million | NT$230.39 Million | NT$24.98 Million | ▼ -86.6% |
| 2022 | 1.54x | NT$40.90 Million | NT$26.62 Million | NT$40.20 Million | ▲ +880.3% |
| 2021 | 0.16x | NT$28.20 Million | NT$179.87 Million | NT$26.20 Million | ▼ -74.4% |
| 2020 | 0.61x | NT$171.51 Million | NT$280.60 Million | NT$48.32 Million | ▲ +112.3% |
| 2019 | 0.29x | NT$133.19 Million | NT$462.52 Million | NT$56.58 Million | ▼ -81.6% |
| 2018 | 1.56x | NT$105.52 Million | NT$67.57 Million | NT$75.29 Million | ▲ +312.9% |
| 2017 | 0.38x | NT$26.79 Million | NT$70.83 Million | NT$26.76 Million | ▲ +101.2% |
| 2016 | 0.19x | NT$56.03 Million | NT$298.06 Million | NT$38.45 Million | ▼ -5.2% |
| 2015 | 0.20x | NT$93.63 Million | NT$472.15 Million | NT$26.66 Million | ▼ -44.4% |
| 2014 | 0.36x | NT$95.47 Million | NT$267.60 Million | NT$65.41 Million | ▼ -40.9% |
| 2013 | 0.60x | NT$292.47 Million | NT$484.77 Million | NT$247.69 Million | ▼ -25.9% |
| 2012 | 0.81x | NT$414.70 Million | NT$509.67 Million | NT$414.70 Million | ▲ +198.1% |
| 2011 | 0.27x | NT$74.63 Million | NT$273.45 Million | NT$74.63 Million | ▼ -21.1% |
| 2010 | 0.35x | NT$161.05 Million | NT$465.59 Million | NT$161.05 Million | ▲ +84.6% |
| 2009 | 0.19x | NT$73.34 Million | NT$391.29 Million | NT$73.34 Million | ▼ -56.7% |
| 2008 | 0.43x | NT$129.74 Million | NT$299.96 Million | NT$129.74 Million | ▲ +188.3% |
| 2007 | 0.15x | NT$54.71 Million | NT$364.62 Million | NT$54.71 Million | ▲ +30.0% |
| 2006 | 0.12x | NT$41.99 Million | NT$363.71 Million | NT$41.99 Million | ▼ -69.9% |
| 2005 | 0.38x | NT$81.30 Million | NT$212.14 Million | NT$81.30 Million | ▼ -66.7% |
| 2004 | 1.15x | NT$251.16 Million | NT$218.54 Million | NT$251.16 Million | ▲ +518.0% |
| 2003 | 0.19x | NT$56.21 Million | NT$302.25 Million | NT$56.21 Million | ▼ -75.8% |
| 2002 | 0.77x | NT$61.13 Million | NT$79.49 Million | NT$61.13 Million | — |